DNA triple helices: biological consequences and therapeutic potential
- PMID: 18331847
- PMCID: PMC2586808
- DOI: 10.1016/j.biochi.2008.02.011
DNA triple helices: biological consequences and therapeutic potential
Erratum in
-
Corrigendum to "DNA Triple Helices: Biological consequences and therapeutic potential" [Biochimie 90/8 (2008) 1117-1130].Biochimie. 2018 May;148:139. doi: 10.1016/j.biochi.2018.03.004. Epub 2018 Mar 23. Biochimie. 2018. PMID: 29580585 No abstract available.
Abstract
DNA structure is a critical element in determining its function. The DNA molecule is capable of adopting a variety of non-canonical structures, including three-stranded (i.e. triplex) structures, which will be the focus of this review. The ability to selectively modulate the activity of genes is a long-standing goal in molecular medicine. DNA triplex structures, either intermolecular triplexes formed by binding of an exogenously applied oligonucleotide to a target duplex sequence, or naturally occurring intramolecular triplexes (H-DNA) formed at endogenous mirror repeat sequences, present exploitable features that permit site-specific alteration of the genome. These structures can induce transcriptional repression and site-specific mutagenesis or recombination. Triplex-forming oligonucleotides (TFOs) can bind to duplex DNA in a sequence-specific fashion with high affinity, and can be used to direct DNA-modifying agents to selected sequences. H-DNA plays important roles in vivo and is inherently mutagenic and recombinogenic, such that elements of the H-DNA structure may be pharmacologically exploitable. In this review we discuss the biological consequences and therapeutic potential of triple helical DNA structures. We anticipate that the information provided will stimulate further investigations aimed toward improving DNA triplex-related gene targeting strategies for biotechnological and potential clinical applications.
Figures
References
-
- Felsenfeld G, Rich A. Studies on the formation of two- and three-stranded polyribonucleotides. Biochim Biophys Acta. 1957;26:457–468. - PubMed
-
- Dervan PB. Design of sequence-specific DNA-binding molecules. Science. 1986;232:464–471. - PubMed
-
- Hoogsteen K. The structure of crystals containing a hydrogen-bonded complex of 1-methylthymine and 9-methyladenine. Acta Cryst. 1959;12:822–823.
-
- Cooney M, Czernuszewicz G, Postel EH, Flint SJ, Hogan ME. Site-specific oligonucleotide binding represses transcription of the human c-myc gene in vitro. Science. 1988;241:456–459. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
